INTRODUCTIONEczema affects approximately 31 million people in the United States and is characterized by dryness, itchiness, scaling, roughness, irritation, or discoloration as well as periodic unpredictable flares.1 Developing a good…
Read More
INTRODUCTIONEczema- or atopy-prone skin frequently has an ineffective skin barrier, which can lead to redness, irritation, and dryness with periods of remission interspersed with flares.1 When their eczema flares, patients…
Read More
INTRODUCTIONEczema, or atopic dermatitis (AD), is a common skin condition which is estimated to affect >31 million people in United States, with up to 25% of children and almost 10%…
Read More
INTRODUCTIONEczema, also called atopic dermatitis, is an inflammatory skin disease characterized by skin barrier damage, which translates to itch, dry skin, rash, scaling, blisters, and skin their eczema flares, patients…
Read More
In this supplement: Brodalumab is an Efficacious, Safe, and Cost-Effective IL-17 Receptor Blocker for the Treatment of Moderate-to-Severe Plaque Psoriasis: 2023 UpdatePsoriasis remains a highly prevalent condition in the United…
Read More
In this supplement:Efficacy of Over-The-Counter Cream in Reducing Eczema SignsEczema affects approximately 31 million people in the United States and is characterized by dryness, itchiness, scaling, roughness, irritation, or discoloration…
Read More
INTRODUCTIONOnychomycosis is a fungal infection of the nails and surrounding skin often presenting as thickening of the nail, onycholysis, and discoloration. It is the most common nail pathology and accounts…
Read More
IntroductionAcute and chronic skin conditions affecting the appearance of visible skin are associated with both physical and psychological symptoms and lower quality of life.1,2 In individuals with skin of color,…
Read More
INTRODUCTIONAtopic dermatitis (AD) is one of the most common inflammatory skin disorders. It is present in both the very young and the very old and is a significant cause of…
Read More
INTRODUCTIONLong-term maintenance of clear skin is a primary treatment goal for most patients with psoriasis. Ineffective response or loss of response to systemic therapy necessitates a change in treatment. In…
Read More
INTRODUCTION1. IL-4 and IL-13 Blockade is Not Immunosuppressive Treating widespread, moderate-to-severe atopic dermatitis (AD) has classically been done with immunosuppressive medications, such as methotrexate, cyclosporine, or azathioprine. Dupilumab changed this…
Read More
INTRODUCTIONRosacea has variable clinical presentation consisting of four overlapping phenotypes: erythematotelangiectatic, papulopustular, phymatous, and ocular.1 Rosacea's pathogenesis involves increased cutaneous density of Demodex folliculorum mites, which drive inflammation through activation…
Read More
